CNO Insider Notice: 9,228 Shares to be Sold via Morgan Stanley

Rhea-AI Filing Summary

CNO Financial Group, Inc. (CNO) Form 144 reports a proposed sale of 9,228 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $349,262.27, based on an approximate sale date of 08/15/2025 on the NYSE. The filing lists total shares outstanding of 96,931,934. The securities were acquired as performance shares on 02/14/2023 (7,479 shares) and as restricted stock on 09/30/2021 (1,749 shares). The filer also reported recent sales: 6,509 shares on 08/14/2025 for $247,203.36 and 9,920 shares on 08/13/2025 for $376,551.30. The notice includes the standard representation regarding material nonpublic information and a broker identification.

Positive

• Transparent disclosure of proposed sale, broker, acquisition dates, and grant types
• Includes recent sale history for the filer (08/13/2025 and 08/14/2025), improving market visibility
• Filed as LIVE and contains the statutory representation regarding material nonpublic information

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale disclosure showing modest volume relative to shares outstanding; no new company operational information.

The filing is procedural: it notifies the market of a planned sale of 9,228 common shares through a registered broker and documents acquisition dates and grant types. The reported recent sales on 08/13/2025 and 08/14/2025 provide additional transparency on prior disposals. The size of the proposed sale (9,228 shares, $349k) is immaterial relative to the reported 96.9 million shares outstanding, suggesting limited direct impact on capitalization or liquidity. No earnings, operational changes, or other material corporate events are disclosed.

Compliance/Risk Analyst

TL;DR: Filing meets Rule 144 disclosure requirements and includes the required representation on material nonpublic information.

The notice identifies the broker, nature and dates of acquisition (performance shares and restricted stock), and recent sales, aligning with Rule 144 reporting expectations. The filer includes the statutory representation about lacking material nonpublic information and the warning about willful misstatement. There is no indication of reliance on a Rule 10b5-1 plan in the data provided. From a compliance perspective, the document appears complete for a standard Form 144 submission.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9228	349262.27	96931934	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/14/2023	Performance Shares	ISSUER			7479	02/14/2023	Not Applicable
Common	09/30/2021	Restricted Stock	ISSUER			1749	09/30/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KAREN DETORO 11299 Illinois Street Carmel IN 46032	Common	08/14/2025	6509	247203.36
KAREN DETORO 11299 Illinois Street Carmel IN 46032	Common	08/13/2025	9920	376551.30

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares did the Form 144 filed for CNO (CNO) report proposed to sell?

The notice reports a proposed sale of 9,228 common shares of CNO with an aggregate market value of $349,262.27 (approximate sale date 08/15/2025).

Who is the broker handling the proposed CNO share sale?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY.

When and how were the securities being sold on the Form 144 acquired?

The securities were acquired as performance shares on 02/14/2023 (7,479 shares) and as restricted stock on 09/30/2021 (1,749 shares) from the issuer.

Did the filer recently sell other CNO shares before this Form 144?

Yes. The filer reported sales of 9,920 shares on 08/13/2025 for $376,551.30 and 6,509 shares on 08/14/2025 for $247,203.36.

How large is the proposed sale relative to CNO's outstanding shares?

The proposed 9,228-share sale is small relative to the reported 96,931,934 shares outstanding noted in the filing.